BioSpace News Archive

TECHLAB® Inc., a leader in infectious disease diagnostics, announced it has partnered with the New River Valley COVID-19 Task Force to cost-effectively expand future COVID-19 testing capacity.

New data to be presented at the American College of Rheumatology Convergence 2020 demonstrate that the efficacy, pharmacokinetics and overall safety of CT-P17, a proposed high concentration and citrate-free adalimumab biosimilar, is comparable to reference adalimumab in the treatment of rheumatoid arthritis patients.

Horizon to host an online discussion with Puja Khanna, M.D., M.P.H., co-primary investigator for RECIPE, on Nov. 10 at 7 p.m. ET

Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, announced further details regarding the outcomes of the Verification Study.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced the appointment of prominent business leader Lara L. Lee to the Board of Directors.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced special activities to support its ongoing commitment to diabetes awareness during the month of November.

It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug Administration of a medicine you have researched and developed.

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated, is scheduled to speak at the Stephens Investment Conference 2020, on Monday, November 16, 2020 at 1:00 p.m..

InspireMD, Inc., the developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by carotid artery disease, announces it will report fiscal third quarter 2020 financial results on Monday, November 9, 2020 before the market opens.

Viela Bio announced it will host a webcast and conference call on Tuesday, November 10, 2020 at 5:00 p.m. EST to discuss its third quarter 2020 financial results and program highlights.